Profound Medical Corp
TSX:PRN
Profound Medical Corp
Accounts Receivables
Profound Medical Corp
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Profound Medical Corp
TSX:PRN
|
Accounts Receivables
$6.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Neovasc Inc
TSX:NVCN
|
Accounts Receivables
$1.9m
|
CAGR 3-Years
46%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Opsens Inc
TSX:OPS
|
Accounts Receivables
CA$8.9m
|
CAGR 3-Years
32%
|
CAGR 5-Years
26%
|
CAGR 10-Years
25%
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Accounts Receivables
CA$8.3m
|
CAGR 3-Years
65%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Theralase Technologies Inc
XTSX:TLT
|
Accounts Receivables
CA$262.2k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-4%
|
|
MedMira Inc
XTSX:MIR
|
Accounts Receivables
CA$1.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
75%
|
CAGR 10-Years
19%
|
See Also
What is Profound Medical Corp's Accounts Receivables?
Accounts Receivables
6.2m
USD
Based on the financial report for Mar 31, 2024, Profound Medical Corp's Accounts Receivables amounts to 6.2m USD.
What is Profound Medical Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
31%
Over the last year, the Accounts Receivables growth was -9%. The average annual Accounts Receivables growth rates for Profound Medical Corp have been 4% over the past three years , 31% over the past five years .